Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
Seminars in Oncology
|
May 2, 2003
Monotherapy options in the management of metastatic breast cancer
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2011
How long is long enough?
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2003
Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
The search for an elusive uniform strategy for a heterogeneous disease: lesson learned?
Andrew D Seidman
Oncology (Williston Park, N.Y.)
|
March 18, 2016
When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
Andrew D Seidman
Clinical Advances in Hematology & Oncology : H&O
|
December 16, 2010
Brain metastases from breast cancer
Andrew D Seidman
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Gemcitabine and docetaxel in metastatic breast cancer
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2005
"Will weekly work"? Seems to be so
Andrew D Seidman
Oncology (Williston Park, N.Y.)
|
September 22, 2006
Systemic treatment of breast cancer. Two decades of progress
Andrew D Seidman
Cancer Chemotherapy and Pharmacology
|
November 8, 2005
Current status of dose-dense chemotherapy for breast cancer
Andrew D Seidman
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
Seminars in Oncology
|
May 2, 2003
Monotherapy options in the management of metastatic breast cancer
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2011
How long is long enough?
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2003
Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
The search for an elusive uniform strategy for a heterogeneous disease: lesson learned?
Andrew D Seidman
Oncology (Williston Park, N.Y.)
|
March 18, 2016
When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
Andrew D Seidman
Clinical Advances in Hematology & Oncology : H&O
|
December 16, 2010
Brain metastases from breast cancer
Andrew D Seidman
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Gemcitabine and docetaxel in metastatic breast cancer
Andrew D Seidman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2005
"Will weekly work"? Seems to be so
Andrew D Seidman
Oncology (Williston Park, N.Y.)
|
September 22, 2006
Systemic treatment of breast cancer. Two decades of progress
Andrew D Seidman
Cancer Chemotherapy and Pharmacology
|
November 8, 2005
Current status of dose-dense chemotherapy for breast cancer
Andrew D Seidman
Page
of 9